TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
ANAB

AnaptysBio Inc

Healthcare · Biotechnology

51.70$ +1.8% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ANAB
Line item 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-5.21 5.89 -3.79 -3.42 -0.98 -1.97 -2.57 -0.52 -1.67 -2.61 -4.49 -4.77 0.63
0.52 0.12 0.11 0.09 0.01 0.01 0.02 0.02 0.08 0.08 0.09 0.08 0.08
0.14 0.06 0.24 0.44 0.22 0.40 0.46 0.42 0.56 0.97 1.23 1.20 1.15
– 0.60 0.78 0.77 0.32 -0.02 0.02 0.44 0.07 0.66 – – –
-1.12 3.74 -2.56 -2.66 0.21 0.14 0.62 -0.25 -0.27 0.24 -0.01 -2.34 -2.58
0.03 0.06 0.09 0.02 0.01 0.04 0.03 0.02 0.05 0.01 0.03 0.01 0.00
-0.03 -0.06 -0.09 -0.02 -12.29 -5.77 4.86 3.46 1.42 -14.02 5.38 3.36 7.28
– – – – 0.00 – – – – – 0.44 – –
– 0.06 16.01 0.00 14.86 9.33 0.11 0.02 0.09 0.42 -1.86 -0.02 -2.19
– 2.02 3.92 3.79 -0.35 -0.28 -0.28 -0.05 0.00 0.00 – – –
1.77 1.98 15.45 3.27 14.78 9.05 -0.17 -0.03 9.20 1.56 -2.20 4.48 -4.23
-3.48 7.81 11.56 -0.17 1.51 1.31 2.12 2.91 8.94 -15.07 -1.31 3.07 3.67
-5.24 5.83 -3.88 -3.44 -1.00 -2.01 -2.60 -0.54 -1.72 -2.63 -4.52 -4.78 0.63

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?